Related Experiment Video
Updated: May 7, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Risk factors for increased antimicrobial resistance: a retrospective analysis of 309 acute cholangitis episodes
Jochen Schneider1, Pierre De Waha, Alexander Hapfelmeier
1Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität München, München, Germany.
Objectives:
To assess the risk factors for increased antimicrobial resistance among Enterobacteriaceae representing the most common biliary pathogens.
Methods:
A retrospective analysis was conducted of 276 patients with acute cholangitis treated at a German tertiary centre between April 1996 and May 2009. The resistance patterns among Enterobacteriaceae isolated from blood/bile cultures were compared and related to age, sex, the genesis of the cholangitis and the type and number of previous interventional procedures [percutaneous transhepatic cholangiography (PTC)/endoscopic retrograde cholangiography (ERC)]. Univariate and multivariate generalized estimation equation models were used to compute ORs with corresponding 95% CIs for the binomial outcomes.
Results:
According to the univariate analysis, patients undergoing stent therapy had a smaller proportion of Enterobacteriaceae with susceptibility to quinolones (ofloxacin/ciprofloxacin) (184/239 versus 205/221; P < 0.001) and to ceftriaxone (208/239 versus 209/222; P = 0.014). Logistic regression analysis revealed that the odds for acquiring ceftriaxone-resistant Enterobacteriaceae were 4-fold higher than in patients who had not undergone stent therapy (P = 0.039). Furthermore, an increased number of interventional procedures (PTC/ERC) was associated with lower susceptibility. The odds for susceptibility to ampicillin, ampicillin/sulbactam, ceftriaxone, quinolones and co-trimoxazole decreased by 2%, 2%, 4%, 6% and 3%, respectively, per interventional procedure. Age, sex and type of interventional procedure displayed no significant relationship to the development of antimicrobial resistance.
Conclusions:
Stent therapy was found to be a risk factor for increased antimicrobial resistance in patients with acute cholangitis, particularly those who had undergone numerous interventional procedures prior to the onset of the cholangitis.
Insights
Stent therapy increases antimicrobial resistance in patients with acute cholangitis. Numerous prior interventional procedures further elevate this risk, impacting treatment effectiveness.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Medicine
Background:
- Enterobacteriaceae are common pathogens in biliary tract infections.
- Antimicrobial resistance (AMR) poses a significant challenge in managing acute cholangitis.
- Identifying risk factors for AMR is crucial for effective treatment strategies.
Purpose of the Study:
- To identify risk factors associated with increased antimicrobial resistance in Enterobacteriaceae causing acute cholangitis.
- To evaluate the impact of interventions and patient characteristics on resistance patterns.
Main Methods:
- Retrospective analysis of 276 patients with acute cholangitis.
- Comparison of resistance patterns in Enterobacteriaceae from blood/bile cultures.
- Analysis of risk factors including age, sex, cholangitis genesis, and interventional procedures (percutaneous transhepatic cholangiography/endoscopic retrograde cholangiography).
- Utilized univariate and multivariate generalized estimation equation models.
Main Results:
- Stent therapy was associated with a lower proportion of susceptible Enterobacteriaceae to quinolones and ceftriaxone.
- Patients undergoing stent therapy had a 4-fold higher odds of acquiring ceftriaxone-resistant Enterobacteriaceae.
- Each additional interventional procedure (PTC/ERC) decreased susceptibility to multiple antibiotics, including quinolones and ceftriaxone.
- Age, sex, and type of intervention were not significant risk factors for AMR.
Conclusions:
- Stent therapy is a significant risk factor for developing antimicrobial resistance in acute cholangitis.
- A higher number of prior interventional procedures exacerbates the risk of antimicrobial resistance.
- These findings highlight the need for careful consideration of interventions in patients with biliary infections and emerging resistance.
Related Concept Videos
Cholecystitis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Acute Pancreatitis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
